Characterizing the ligand-binding mechanisms of human anti-apoptotic Bcl-2 protein through insilico studies
Georgian Biomaterials Journal · 30.06.2025 · 1 (1)
DOI: 10.62343/geobioj.2025.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Georgian Biomaterials Journal, online erschienen am 30.06.2025. Verfasst von Neda Tamimi.
Abstract (Originalsprache)
Due to its central role in controlling apoptosis, Bcl-2 has attracted interest as a viable target in cancer therapy. This research aims to explore the structural dynamics and stability of Bcl-2 upon binding with the inhibitor Asiaticoside, while also identifying additional viable sites for drug targeting. We employed insilico methods to gain insights into the ligand binding mechanism Bcl-2. Regulation of apoptosis significantly depends on the flexible loop domain (FLD).
Zitieren
APA
Tamimi, N. (2025). Characterizing the ligand-binding mechanisms of human anti-apoptotic Bcl-2 protein through insilico studies. Georgian Biomaterials Journal, 1(1). https://doi.org/10.62343/geobioj.2025.7
Vancouver
Tamimi N. Characterizing the ligand-binding mechanisms of human anti-apoptotic Bcl-2 protein through insilico studies. Georgian Biomaterials Journal. 2025;1(1). doi:10.62343/geobioj.2025.7
BibTeX
@article{Tamimi2025,
author = {Tamimi, Neda},
title = {Characterizing the ligand-binding mechanisms of human anti-apoptotic Bcl-2 protein through insilico studies},
journal = {Georgian Biomaterials Journal},
year = {2025},
volume = {1},
number = {1},
doi = {10.62343/geobioj.2025.7}
}
EUVIMED